These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. The role of prekallikrein and high-molecular-weight kininogen in the contact activation of Hageman factor (factor XII) by sulfatides and other agents. España F; Ratnoff OD J Lab Clin Med; 1983 Oct; 102(4):487-99. PubMed ID: 6604770 [TBL] [Abstract][Full Text] [Related]
4. The normal coagulation mechanism. Bennett B; Ratnoff OD Med Clin North Am; 1972 Jan; 56(1):95-104. PubMed ID: 4550195 [No Abstract] [Full Text] [Related]
5. Prolongation of the activated partial thromboplastin time associated with poor venipuncture technic. McPhedran P; Clyne LP; Ortoli NA; Gagnon PG; Sanders FJ Am J Clin Pathol; 1974 Jul; 62(1):16-20. PubMed ID: 4833734 [No Abstract] [Full Text] [Related]
6. Notes on clotting in a Burmese python (Python molurus bivittatus). Ratnoff OD; Rosenberg MJ; Everson B; Emanuelson M; Tulodziecki N J Lab Clin Med; 1990 May; 115(5):629-35. PubMed ID: 2341766 [TBL] [Abstract][Full Text] [Related]
7. [Partial thromboplastin time. Change in time by alteration of the concentration of single blood coagulation factors using reagents from various producers. Effect of heparin on partial thromboplastin time]. Averdunk R; Braun JS Blut; 1972 Jun; 24(6):372-81. PubMed ID: 5042320 [No Abstract] [Full Text] [Related]
8. THROMBOPLASTIN FORMATION. POOL JG Annu Rev Med; 1964; 15():215-32. PubMed ID: 14133846 [No Abstract] [Full Text] [Related]
9. The coagulant activity of platelets. Biggs R; Denson KW; Riesenberg D; McIntyre C Br J Haematol; 1968 Sep; 15(3):283-96. PubMed ID: 5303048 [No Abstract] [Full Text] [Related]
10. Interaction of heparin with canine coagulation proteins: in vivo and in vitro studies. Gentry PA Can J Comp Med; 1977 Oct; 41(4):396-403. PubMed ID: 922557 [TBL] [Abstract][Full Text] [Related]
11. Inhibition of the activation of Hageman factor (factor XII) by platelet factor 4. Dumenco LL; Everson B; Culp LA; Ratnoff OD J Lab Clin Med; 1988 Sep; 112(3):394-400. PubMed ID: 3045234 [TBL] [Abstract][Full Text] [Related]
12. The mechanism of blood coagulation. Owren PA; Stormorken H Ergeb Physiol; 1973; 68():1-53. PubMed ID: 4593726 [No Abstract] [Full Text] [Related]
13. [The physiology of blood platelets]. Lüscher EF Schweiz Med Wochenschr; 1968 Oct; 98(42):1629-35. PubMed ID: 5698340 [No Abstract] [Full Text] [Related]
14. Theories of blood coagulation. Properties and interactions of blood clotting factors. Kazal LA Ann Clin Lab Sci (1971); 1971; 1(2):139-54. PubMed ID: 4949446 [No Abstract] [Full Text] [Related]
18. Inhibition of activated Hageman factor and activated plasma thromboplastin antecedent by purified serum C1 inactivator. Forbes CD; Pensky J; Ratnoff OD J Lab Clin Med; 1970 Nov; 76(5):809-15. PubMed ID: 5477337 [No Abstract] [Full Text] [Related]
19. The chemistry of blood coagulation. Baugh RF; Hougie C Clin Haematol; 1979 Feb; 8(1):3-30. PubMed ID: 367664 [No Abstract] [Full Text] [Related]
20. THE INDUCTION OF PERMEABILITY-INCREASING ACTIVITY IN HUMAN PLASMA BY ACTIVATED HAGEMAN FACTOR. RATNOFF OD; MILES AA Br J Exp Pathol; 1964 Jun; 45(3):328-45. PubMed ID: 14173175 [No Abstract] [Full Text] [Related] [Next] [New Search]